ViiV Healthcare announces U.S. approval of TivicayA (dolutegravir) for the treatment of HIV-1

... that our singular focus on HIV can deliver important new medicines, maintaining our absolute commitment to the HIV/AIDS global response," said Dr Dominique Limet, Chief Executive Officer, ViiV Healthcare. The submission included data from four ...

http://www.pressreleasepoint.com/viiv-healthcare-announces-us-approval-tivicay%C2%AE-dolutegravir-treatment-hiv-1